Kyverna Therapeutics, Inc.
KYTX
$2.30
$0.12475.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.38% | 396.98% | -- | -- | 620.54% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -12.15% | 48.09% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.05% | 379.03% | 309.74% | -- | -- |
|
|
|||||
| Total Current Assets | -34.05% | 379.03% | 309.74% | -- | -- |
| Net Property, Plant & Equipment | -30.97% | 0.43% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 140.88% | -13.59% | -- | -- | -- |
| Total Assets | -33.16% | 305.14% | 266.75% | -- | -- |
|
|
|||||
| Total Accounts Payable | 13.70% | 6.10% | -- | -- | -- |
| Total Accrued Expenses | 98.53% | 22.85% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.58% | 34.93% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 299.52% | -- | -- | -- |
| Total Other Current Liabilities | -- | 299.52% | -- | -- | -- |
| Total Current Liabilities | 52.26% | 69.98% | 83.63% | -- | -- |
|
|
|||||
| Total Current Liabilities | 52.26% | 69.98% | 83.63% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -52.96% | -30.15% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.39% | 46.28% | 53.83% | -- | -- |
|
|
|||||
| Common Stock & APIC | 1.61% | 11,317.54% | -- | -- | -- |
| Retained Earnings | -89.36% | -93.70% | -95.91% | -- | -- |
| Treasury Stock & Other | 0.00% | 2,525.00% | -- | -- | -- |
| Total Common Equity | -37.95% | 302.89% | 370.75% | -- | 587.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.95% | 302.89% | 370.75% | -- | 587.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.95% | 442.10% | -- | -- | 673.38% |
|
|
|||||